Year: 2025

Onco-Innovations’ Technology Shown in Study to Successfully Inactivate DNA Repair in Cancer, Potentially Boosting Radiation Therapy Effectiveness

VANCOUVER, BC / ACCESSWIRE / January 9, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased...

J.P. Morgan Healthcare Conference 2025: Genomics Announces Dr Jose-Carlos Gutiérrez-Ramos as New Board Member to Accelerate Global Expansion and Life Sciences R&D Growth

Dr Jose-Carlos Gutiérrez-Ramos is the Chief Science Officer at Danaher Corporation. He has held senior drug discovery roles at Pfizer,...

error: Content is protected !!